| TigerSoft Blog www.tigersoftware.com
See www.tigersoft.com Contact firstname.lastname@example.org 858-273-5900
SAN DIEGO STOCK's PERFORMANCE
since June 1010
WHERE TO GO FIRST FOR
BIOTECH JOBS IN SAN DIEGO
3/26/2011 (C) 2011 Wm.Schmidt, Ph.D.
We look back to June 30th, 2010 to measure the performance of
San Diego's stocks to see if we can help some people we know
get a new job. We start at the last "reversing" buy signal from our
Peerless Stock Market Timing system. There has not been a major
market sell since then; the DJI has risen more than 25% in this
period. San Diego's companies' stocks are mostly lagging, but
the ones that are not are definitely better prospects for finding a
job than the ones whose stocks are falling.
Stock investors, read our TigerSoft and Peerless documentation
on using our Insider Trading Charts with automatic Buys and Sells.
how to start using it at www.tigersoft.com
PEERLESS BUYS/SELLS on DJIA
(C) 2011 William Schmidt, Ph.D. www.tigersoft.com 3/25/2011
We recommend looking at the stocks in your area if you are looking for a job. The
stocks that are going up tend to be companies that are expanding and hiring. We also
suggest you show your interviewer our TigerSoft chart of their company. They will
probably be interested in the buys and sells it shows the optimum trading system
They will be intrigued at how professional traders whip the stock up and down. They
will be also want to know whether the stock shows Insider Buying or Selling
(See Tiger Accumulation Index) and Professional Buying or Selling (See Tiger Closing Power).
These lie at the heart of our Tiger trading tools. See our discussion of how
we measure insider buying. "
Wall Street versus Main Street
San Diego's stocks are underperforming the much watched Dow Jones Industrial
Average. Wall Street's blue chips are doing much better than Main Street's smaller
companies. See this in the chart below. There have been many criticisms lodged
against Wall Street and Washington for subsidizing the very rich, big Wall Street banks
and the biggest multinational corporations while largely neglecting the rest of America,
the poor, the unemployed.
US experiencing uneven job growth across states
The Tiger Index of San Diego Stocks is an index, where companies are
GPRO Gen-Probe Inc. 10210 Genetic Center Drive
San Diego, CA 92121 - Map
SAN DIEGO STOCKS' Performance based on 185 Days back. 6 / 30 / 2010 - 3 / 25 / 2011 Rank Symbol Name Price Pct.Gain --------- ----------------------------------- ---------- ------------ 1 ROYL ROYALE ENERGY INC 5.32 167% Royale Energy, Inc. operates as an independent oil and natural gas producer in the United States. 22 employees. 7676 Hazard Center Drive Suite 1500 San Diego, CA 92108 Phone: 619-881-2800 Website: http://www.royl.com 2 CYTX Cytori Therapeutics 7.57 117% Cytori Therapeutics, Inc. 3020 Callan Road San Diego, CA 92121 United States - Map Phone: 858-458-0900 Fax: 858-458-0994 Website: http://www.cytoritx.com number of employees not available Cytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical technologies to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. The company develops its product pipeline for the treatments of cardiovascular disease, spinal disc degeneration, gastrointestinal disorders, liver and renal disease, and pelvic health conditions. Its principal products include the Celution family of products, which processes patients' adipose-derived stem and regenerative cells (ADRCs) at the point of care. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzymes, and related instrumentation. Its core product, the Celution System, provides physicians with clinical grade stem and regenerative cells for use in the cosmetic and reconstructive surgery market. It also intends to offer the PureGraft System in the U.S as a medical device that prepares autologous fat grafts for use in aesthetic body contouring. The company also sells the StemSource family of products worldwide, including in the United States, for research, as well as for the cryopreservation and storage of ADRCs. It offers the StemSource System as a standalone product, or as a part of a comprehensive suite of systems, equipment, and protocols collectively referred to as a StemSource Cell Bank. The company also develops Celution System for applications in cardiovascular disease, wound healing, gastrointestinal disorders, stress urinary incontinence, liver and renal disease spinal disc degeneration, and pelvic health conditions. 3 HILL Dot Hill Systems Corp. 2.4 101% - Dot Hill Systems Corp. 1351 South Sunset Street Suite 100 Longmont, CO 80501-6533 United States - Map Phone: 303-845-3200 Fax: 303-845-3365 Website: http://www.dothill.com 293 employees Dot Hill Systems Corp. provides entry-level and midrange storage systems and enterprise server software for organizations requiring networked storage and data management solutions in open systems architecture.
4 CYMI CYMER INC. 54.83 82% Cymer Inc. 17075 Thornmint Court San Diego, CA 92127 United States - Map Phone: 858-385-7300 Fax: 858-385-7100 Website: http://www.cymer.com 953 employees Cymer, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of excimer light sources for the manufacturers of photolithography tools in the semiconductor equipment industry. 5 CDFB CORONADO FIRDT BANK 5.15 80% Coronado First Bank 801 Orange Avenue Suite 101 Coronado, CA 92118 United States - Map Phone: 619-437-1000 Fax: 619-437-1070 Website: http://www.coronadofirst.com
6 QCOM QUALCOMM INCORPOR 52.75 60% QUALCOMM Incorporated 5775 Morehouse Drive San Diego, CA 92121-1714 United States - Map Phone: 858-587-1121 Fax: 858-658-2100 Website: http://www.qualcomm.com 17,500 employees 7 SNMX Senomyx Inc. 6.05 59% Senomyx Inc. 4767 Nexus Centre Drive San Diego, CA 92121 United States - Map Phone: 858-646-8300 Fax: 858-404-0752 Website: http://www.senomyx.com 108 employees
Senomyx, Inc. engages in the discovery and development of flavor ingredients in the savory, sweet, salt, bitter, and cooling areas using proprietary taste receptor technologies. The company has product discovery, development, and commercialization collaborations with seven food, beverage, and ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is marketing products that contain one of Senomyx?s flavor ingredients. 8 CUB CUBIC CP 56.31 54% Cubic Corporation 9333 Balboa Avenue San Diego, CA 92123 United States - Map Phone: 858-277-6780 Fax: 858-277-1878 Website: http://www.cubic.com 7700 employees Cubic Corporation designs, develops, manufactures, and installs military electronics and transportation fare collection systems. Its Mission Support Services segment provides live, virtual, and constructive training services for the U.S. and allied militaries, as well as force modernization, battle command training, professional military education, leader development, intelligence systems training, open-source analysis, operations and maintenance support, logistics support, and weapons effects modeling services. 9 RFIL RF INDUSTRIES LTD 4.05 53% RF Industries Ltd. 7610 Miramar Road Suite 6000 San Diego, CA 92126-4202 United States - Map Phone: 858-549-6340 Fax: 858-549-6345 Website: http://www.rfindustries.com 110 employees RF Industries, Ltd. provides interconnect products and systems for radio frequency (RF) communications devices and wireless digital transmission systems in the United States and internationally. Its Connector and Cable Assembly division designs, manufactures, and distributes coaxial connectors and cable assemblies. The company's Aviel Electronics division engages in the design, manufacture, and distribution of specialty and custom RF connectors primarily for aerospace and military customers.
10 ILMN Illumina Inc. 65.45 50% Illumina Inc. 9885 Towne Centre Drive San Diego, CA 92121 United States - Map Phone: 858-202-4500 Fax: 858-587-4297 Website: http://www.illumina.com 2100 employees
llumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include HiSeq 2000, an instrument for high-throughput (up to 200 Gb per run and up to 25 GB per day) sequencing using sequencing-by-synthesis (SBS) technology; Genome Analyzer IIx, an instrument for medium to high-throughput (up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer IIe, an instrument for low to medium throughput (up to 40 Gb per run) sequencing using SBS technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The company?s consumables consist of InfiniumHD Whole-Genome BeadChips comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, which are multi-sample DNA analysis microarrays; iSelect Custom Genotyping BeadChips that are customer designable SNP genotyping arrays; GoldenGate Assay Method, a high throughput assay and genotyping system; GoldenGate Universal-32 Sample BeadChip, which are 32 sample GoldenGate genotyping arrays; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200?500 kb insert paired-end reads; VeraCode GoldenGate that are low plex GoldenGate genotyping arrays compatible with the BeadXpress System; Standard Sequencing Kit, reagents used for SBS chemistry on sequencing platforms; and Infinium Assay Kit, reagents used to perform Infinium assays on the iScan platform. It also provides sequencing and genotyping services.
11 ACAD Acadia Pharmaceuticals Inc. 1.62 48% ACADIA Pharmaceuticals, Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 United States - Map Phone: 858-558-2871 Fax: 858-558-2872 Website: http://www.acadia-pharm.com 27 employees ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, focuses on drug discovery and clinical development of novel treatments for central nervous system disorders. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase III clinical development as a treatment for Parkinson's disease psychosis. It is also developing AGN XX/YY, a product candidate in Phase II for chronic pain; and AC-262271, a product candidate in Phase I for glaucoma, both in collaboration with Allergan, as well as AM-831, a product candidate in IND-track development for schizophrenia in collaboration with Meiji Seika Kaisha. The product candidates in the company?s pipeline emanate from discoveries made using its proprietary drug discovery platform.
12 PSMT PRICESMART INC. 34.57 48% 13 MXWL MAXWELL TECHNOLOG 16.77 47% Maxwell Technologies Inc. 5271 Viewridge Court Suite 100 San Diego, CA 92123 United States - Map Phone: 858-503-3200 Fax: 858-503-3301 Website: http://www.maxwell.com 314 employees Maxwell Technologies, Inc. develops, manufactures, and markets energy storage and power delivery products, and microelectronic products.
14 AVNR AVANIR PHARMACEUT 3.77 46% AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States and Canada. Its lead product candidate includes Zenviatm, which has completed three Phase III clinical trials for the treatment of pseudobulbar affect; and a Phase III trial for the treatment of patients with diabetic peripheral neuropathic pain. Avanir Pharmaceuticals 101 Enterprise Suite 300 Aliso Viejo, CA 92656 United States - Map Phone: 949-389-6700 Website: http://www.avanir.com 128 employees 15 GPRO Gen-Probe Inc. 65.31 43% Gen-Probe Inc. 10210 Genetic Center Drive San Diego, CA 92121 United States - Map Phone: 858-410-8000 Fax: 858-410-8625 Website: http://www.gen-probe.com 1363 employees Gen-Probe Incorporated engages in the development, manufacture, and marketing of nucleic acid tests used primarily to diagnose human diseases and screen donated human blood in North America and internationally. The company markets a portfolio of products to detect infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, and other infections. Its primarily product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The company?s product line also include APTIMA HIV-1 assay to detect RNA from HIV-1, the virus that causes AIDS; APTIMA HCV assay to detect RNA from the hepatitis C virus; and ASRs for quantitative HCV testing to quantify HCV viral load. It also offers Pro-Flu+, Pro-Flu ST, ProGastro Cd, AMPLIFIED MTD, and GAS Direct for various respiratory infectious diseases; LIFECODES HLA DNA typing kits and LIFECODES LifeScreen antibody screening kits in the transplant diagnostics field; Procleix HIV-1/HCV assay, Procleix Ultrio assay, Procleix Ultrio Plus assay, and Procleix WNV assay for the blood donor screening market; and TIGRIS and Direct Tube Sampling instrument systems to develop instrumentation. In addition, the company?s developing products include PANTHER, an automated testing instrument. Further, the company offers PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 gene. The company?s customers include reference laboratories, public health institutions, and hospitals.
16 RDEA ARDEA BIOSCIENCES 27.93 35% Ardea Biosciences, Inc. 4939 Directors Place San Diego, CA 92121 United States - Map Phone: 858-652-6500 Fax: 858-652-0760 Website: http://www.ardeabiosciences.com number of employees - unknown rdea Biosciences, Inc., a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), and cancer in the United States. The company?s products include RDEA594, a Phase IIb clinical trial product for the treatment of gout; RDEA684, a preclinical trial product for the treatment of gout with hyperuricemia; RDEA806, a non-nucleoside reverse transcriptase inhibitor, which completed Phase II clinical trial for the treatment of patients with HIV; and RDEA427, which is in first-in-human micro-dose pharmacokinetic study for the treatment of HIV infection. It is evaluating RDEA119, an inhibitor of Mitogen-activated ERK kinase (MEK), which is in Phase I/II study in combination with sorafenib and as a single agent in a Phase I study, both in advanced cancer patients. The company has a license agreement with Bayer to develop and commercialize MEK inhibitors for various indications.
17 SNTS Santarus Inc. 3.28 32% Santarus Inc. 3721 Valley Centre Drive 4th Floor San Diego, CA 92130 United States - Map Phone: 858-314-5700 Fax: 858-314-5701 Website: http://www.santarus.com 335 employees Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company commercializes CYCLOSET (bromocriptine mesylate) tablets, and focuses to commercialize GLUMETZA (metformin hydrochloride extended release tablets) that are indicated as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes. It also has a development pipeline with three late-stage product candidates in Phase III clinical programs, including ULTESA ( budesonide MMX) for induction of remission of active ulcerative colitis, rifamycin SV MMX for treatment of travelers? diarrhea, and RHUCIN (recombinant human C1 inhibitor) for the treatment of acute attacks of hereditary angioedema. In addition, Santarus plans to initiate a Phase I clinical study for SAN-300, an anti-VLA-1 antibody development compound that it expects to develop for the treatment of rheumatoid arthritis.
18 DXCM DexCom 14.64 26% DexCom, Inc. 6340 Sequence Drive San Diego, CA 92121 United States - Map Phone: 858-200-0200 Fax: 858-200-0201 Website: http://www.dexcom.com 405 employees DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. The company also provides the SEVEN PLUS, which incorporates additional user interface and algorithm enhancements that are intended to make its glucose monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark approvals. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. It also has development agreement with Insulet Corporation to integrate its continuous glucose monitoring technology into Insulet?s wireless, handheld OmniPod System Personal Diabetes Manager; and a joint development agreement with Animas Corporation to integrate its continuous glucose monitoring technology into Animas insulin pumps.
19 DRAD Digirad Corp. 2.58 24% Digirad Corporation 13950 Stowe Drive Poway, CA 92064-8803 United States - Map Phone: 858-726-1600 Fax: 858-726-1700 Website: http://www.digirad.com 349 employees The company operates in two segments, Digirad Imaging Solutions and Product. The Digirad Imaging Solutions segment offers various personnel and equipment leasing services for physicians to perform nuclear imaging, echocardiography, vascular ultrasound, or any combination of these procedures in their offices by leasing the imaging system, certified personnel, and other support required to perform imaging. This segment primarily serves cardiologists and internists. 20 ECPG Encore Capital Group Inc. 25.63 24% http://www.encorecapitalgroup.com 1891 employees purchases and manages charged-off consumer receivable portfolios. Its receivable portfolios include unsecured, charged-off domestic consumer credit cards, auto loan deficiency, and telecom receivables purchased from national financial institutions, major retail credit corporations, telecom companies, and resellers.
21 WDFC WD-40 COMPANY 41.64 24% 22 NBIX NEUROCRINE BIOSCI 6.79 21% Neurocrine Biosciences Inc. 12780 El Camino Real San Diego, CA 92130 United States - Map Phone: 858-617-7600 Fax: 858-617-7601 Website: http://www.neurocrine.com 66 employees Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine-related diseases and disorders. Its products in clinical development include Elagolix, a phase II product for endometriosis; CRF1 Antagonist, a phase II product for mood disorders; CRF2 Peptide Agonist, a phase II drug for cardiovascular diseases; CRF1 Antagonist, a phase I product for treating mood disorders and irritable bowel syndrome; Vesicular Monoamine Transporter 2 Inhibitor, a phase I product for movement disorders and schizophrenia; and Elagolix, a phase I product for uterine fibroids, and men?s and women?s health. The company?s research programs comprise Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic Drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. Its product pipeline also includes Indiplon 5mg and 10mg capsules, the FDA deemed approvable products, for the treatment of insomnia.
23 SHW SHERWIN WILLIAMS 83.85 21% 24 VSAT VIASAT INC. 39.46 21% ViaSat Inc. 6155 El Camino Real Carlsbad, CA 92009 United States - Map Phone: 760-476-2200 Fax: 760-929-3941 Website: http://www.viasat.com 2000 employees ViaSat, Inc. engages in the design, production, and marketing of satellite and other wireless communication, and networking systems for government and commercial customers.
25 COHU COHU INC. 14.67 20%
26 WBSN Websense Inc. 22.83 20% 27 ACCL Accelrys Inc. 7.64 18% Accelrys Inc. 10188 Telesis Court Suite 100 San Diego, CA 92121 United States - Map Phone: 858-799-5000 Fax: 858-799-5100 Website: http://www.accelrys.com number of employees - not known Accelrys, Inc. engages in the design, development, marketing, and support of software based solutions that facilitate the discovery and development of products and processes in the pharmaceutical, biotechnology, energy, chemicals, aerospace, and consumer packaged goods industries worldwide. The company offers scientific informatics platform, which allows users to aggregate, integrate, and mine the quantities of structured and unstructured scientific data, such as chemical structures, biological sequences, and digital images, as well as filters, normalizes, and performs statistical analysis on scientific data and provides interactive visual reports to scientists and scientific managers. It also provides computer aided design modeling and simulation software that allows scientists to perform computations of chemical, biological, and materials properties to simulate, visualize, and analyze chemical and biological systems, as well as to communicate the results to other scientists; and cheminformatics software, which is designed to capture, store, manage, and mine chemical information. In addition, the company offers a range of solutions from software wrappers that allows customers to run their own algorithms on scientific informatics platform to enterprise-wide informatics systems, which integrate customers? internal systems with software from various vendors; contract research services; onsite training and implementation services, Web-based training, and data migration services; and support services.
28 OVRL OVERLAND STORAGE 2.4 18% 29 LEAP LEAP WIRELESS INT 15.02 15% 30 BMR BioMed Realty Trust Inc. 18.45 14%
31 ELY CALLAWAY GOLF CP 6.89 14% 32 O REALTY INCOME CP 34.62 14% 33 LGND LIGAND PHARMACEUT 10.29 13% 34 SRE SEMPRA ENERGY 52.49 12% 35 AHS AMN HEALTHCARE SV 8.21 9%
36 INO Inovio Biomedical Corp. 1.12 9% 37 BOFI BofI Holding 15.27 8% 38 ALDA ALDILA INC. 4.3 7% 39 SQNM Sequenom Inc. 6.07 2% The stocks below show losses.
40 SAI SAIC INC 16.68 -1% 41 RMD ResMed Inc. 30.05 -2% 42 PICO PICO Holdings 29.01 -4% -3.8% 43 NVTL Novatel Wireless Inc. 5.36 -7% 44 QDEL QUIDEL CORPORATIO 11.85 -7% 45 ISIS ISIS Pharmaceuticals Inc. 8.74 -9% 46 MITI MICROMET INC. 5.48 -13% 47 VICL VICAL INCORPORATE 2.5 -20% 48 SOMX Somaxon Pharmaceuticals 2.77 -24% 49 TNXI Telanetix .038 -24% 50 NUVA NuVasive 25.2 -29% 51 PURE PURE BIOSCIENCE 1.61 -33% 52 LJPC LA JOLLA PHARMACE .028 -40% 53 XNN Xenonics HoldingsAHS .21 -40% 54 ANDS Anadys Pharmaceuticals Inc. 1.14 -41% 55 AMLN Amylin Pharmaceuticals Inc. 10.54 -44% 56 ARNA Arena Pharmaceuticals Inc. 1.45 -53%